Clinical Course of Relapsing Remitting Multiple Sclerosis Post-Natalizumab.

In conclusion, fingolimod is an effective therapy post-natalizumab. PMID: 31113500 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31113500?dopt=Abstract

Source: The Canadian Journal of Neurological Sciences - May 21, 2019 Category: Neurology Authors: Fiander MDJ, Bhan V, Stewart SA, Parks NE Tags: Can J Neurol Sci Source Type: research